Renalytix AI plc (RENX) ORD GBP0.01 REG S

- Add to watchlist
- Create an alert
- This stock can be held in a




Share news, reports & tips
-
Renalytix AI enters chronic kidney disease partnership with DaVita
5 January 2021 09:31
(Sharecast News) - Artificial intelligence (AI) diagnostics company Renalytix AI announced on Tuesday that it was partnering with DaVita on a programme aimed at slowing disease progression and improving...
-
Renalytix AI commercially launches KidneyIntelX
18 September 2020 12:49
(Sharecast News) - Artificial intelligence kidney diagnostics technology company Renalytix AI announced the commercial launch of its 'KidneyIntelX' clinical test reporting platform within the Mount...
-
Renalytix to work on chronic disease strategies with AstraZeneca
21 August 2020 08:08
(Sharecast News) - Artificial intelligence diagnostics company Renalytix AI revealed on Friday that it will collaborate with pharmaceutical giant AstraZeneca to help improve outcomes for patients with...
-
Renalytix AI gets clinical laboratory permit in New York state
12 June 2020 12:33
(Sharecast News) - Artificial intelligence (AI) in vitro diagnostics company Renalytix AI has received a clinical laboratory permit from the New York State Department of Health (NYS DOH) to provide...
-
Renalytix AI upbeat on latest 'KidneyIntelX' research
10 June 2020 09:26
(Sharecast News) - Artificial intelligence (AI)-focussed diagnostics company Renalytix AI revealed more details of results from a multi-centre clinical validation of 'KidneyIntelX' on Wednesday,...
-
US national pricing comes into effect for Renalytix AI
3 January 2020 08:46
(Sharecast News) - Artificial intelligence-enabled kidney disease clinical diagnostics technology company Renalytix AI announced on Friday that the United States national price for its...
-
Renalytix AI gets national Medicare pricing for 'KidneyIntelX' in US
3 December 2019 09:33
(Sharecast News) - Artificial intelligence-enabled kidney disease diagnostics provider Renalytix AI announced on Tuesday that the Centers for Medicare and Medicaid Services (CMS) has released the final 2020...
-
Renalytix AI gets preliminary Medicare pricing for 'KidneyIntelX'
30 September 2019 10:10
(Sharecast News) - Artificial intelligence-enabled kidney disease clinical diagnostics developer Renalytix AI announced on Monday that Centers for Medicare & Medicaid Services (CMS) has published its...
-
Renalytix AI expands 'KidneyIntelX' investigator group with three appointments
6 August 2019 15:04
(Sharecast News) - Kidney disease artificial intelligence diagnostics developer Renalytix AI announced the expansion of its core investigator group for its lead product 'KidneyIntelX', for earlier...
-
Renalytix AI appoints Thomas McLain as chief commercial officer
29 July 2019 09:23
(Sharecast News) - Artificial intelligence-enabled diagnostics developer Renalytix AI named industry vet Thomas McLain as president and chief commercial officer of the group on Monday, effective immediately.
-
Renalytix AI prepares for US roll-out with CPT code
1 July 2019 14:56
(Sharecast News) - Artificial intelligence-based kidney disease clinical diagnostics developer Renalytix AI announced on Monday that the American Medical Association (AMA) has granted a 'CPT Proprietary...
-
Sunday share tips: CYBG, Renalytix AI
16 June 2019 15:00
(Sharecast News) - In her 'Inside the City' column for the Sunday Times, Emma Dunkley opened by lamenting the state of the challenger bank market, writing that instead of "shaking up" the...
Company announcements Announcements
-
Price Monitoring Extension
13 January 2021 16:35
Renalytix Ai (Reg S)
-
Finalization of MCIT rule for coverage pathway
13 January 2021 07:00
Renalytix Ai (Reg S)
-
Second Price Monitoring Extn
5 January 2021 16:41
Renalytix Ai (Reg S)
-
Price Monitoring Extension
5 January 2021 16:36
Renalytix Ai (Reg S)
-
Partnership Between RenalytixAI and DaVita
5 January 2021 07:00
Renalytix Ai (Reg S)
-
Result of AGM
7 December 2020 15:45
Renalytix Ai (Reg S)
-
Partnership with National Kidney Foundation
2 December 2020 13:08
Renalytix Ai (Reg S)
-
Holding(s) in Company
26 November 2020 07:01
EKF Diagnostics Holdings
-
Sale of shares in Renalytix AI plc
26 November 2020 07:00
EKF Diagnostics Holdings
-
Second Price Monitoring Extn
25 November 2020 16:41
Renalytix Ai (Reg S)
-
Price Monitoring Extension
25 November 2020 16:35
Renalytix Ai (Reg S)
-
Financial Results for First Quarter of FY 2021
25 November 2020 07:00
Renalytix Ai (Reg S)
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2021. All rights reserved.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.